Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 31, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 5, 2026
DirectorIndirect holdingGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001878313-26-000016
Filed / recorded
Jan 5, 2026, 6:42 PM UTC
Added to OQRO
Oct 8, 2026, 2:06 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
MAIA Biotechnology, Inc.
Issuer CIK
1878313
Ticker
MAIA
Reporting person
Stan Smith
Relationship
Director
Security
Options
Table
Derivative (Table II)
Transaction date
Dec 31, 2025
Transaction code
A
Shares / units
29,216
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
29,216
Ownership form
Indirect — See footnote
Amendment
No
Footnotes from the filing
The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.